Inclusion criteria |
Willingness to and capacity for giving written informed consent |
Age ≥18 y |
Systolic blood pressure (SBP) ≥130 mm Hg but <160 mm Hg |
Willingness to comply with all study‐related procedures |
Exclusion criteria |
Pregnancy or postpartum ≤3 months |
Currently taking blood pressure–lowering medications or dietary supplements (eg, magnesium, potassium, calcium >1200 mg/d, fish oil, ephedra, hawthorn, forskolin) |
Stage 2 hypertension (SBP >160 mm Hg OR diastolic blood pressure ≥100 mm Hg) |
Nondominant arm circumference >50 cm |
Body mass index ≥40.0 kg/m2
|
Practiced yoga >1 time per month in the previous 6 months |
Diabetes mellitus or established cardiovascular disease |
Known arrhythmias such as atrial flutter or fibrillation or cardiac pacemaker |
Any tobacco use (within the previous 30 days) |
History of chronic kidney disease based on estimated glomerular filtration rate <60 mL/min |
Consumption of >7 alcoholic drinks per week (for women) and >14 drinks per week (for men) Known autonomic neuropathy (eg, Shy‐Drager syndrome, orthostatic hypotension) |
Known secondary causes of hypertension (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronism) |
Use of benzodiazepines, antipsychotic drugs (3‐month stable use of selective serotonin reuptake inhibitors allowed), or steroids |
Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga |
Practice of other mind‐body therapies such as qigong, tai chi, or meditation |